LI Xinli, SHEN Lei, LU Yuan, FEI Mei, LI Jianzhong, XU Deyu, ZHOU Ling, LU Guoyuan. Evaluation value of systemic immune inflammation index for left ventricular hypertrophy in non-dialysis patients with chronic kidney disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 44-49. DOI: 10.7619/jcmp.20213497
Citation: LI Xinli, SHEN Lei, LU Yuan, FEI Mei, LI Jianzhong, XU Deyu, ZHOU Ling, LU Guoyuan. Evaluation value of systemic immune inflammation index for left ventricular hypertrophy in non-dialysis patients with chronic kidney disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 44-49. DOI: 10.7619/jcmp.20213497

Evaluation value of systemic immune inflammation index for left ventricular hypertrophy in non-dialysis patients with chronic kidney disease

More Information
  • Received Date: August 29, 2021
  • Available Online: March 04, 2022
  • Published Date: February 14, 2022
  •   Objective  To investigate the incidence and risk factors of left ventricular hypertrophy (LVH) in non-dialysis patients with chronic kidney disease (CKD), and to analyze the value of systemic immune inflammation index (SII) in evaluating LVH.
      Methods  A total of 196 non-dialysis patients with CKD were selected as study subjects (CKD group). According to gender, 196 cases were divided into male CKD group (n=117) and female CKD group (n=79), and 40 healthy subjects in the same period were selected as control group. The laboratory indexes and cardiac ultrasound data of three groups were collected and analyzed. The correlation between left ventricular mass index (LVMI) and other indexes was analyzed. Logistic regression was used to analyze the risk factors of LVH and the relationship between SII and LVH(P<0.05).
      Results  The prevalence of LVH in male and female was 31.62% and 50.63%, respectively. Increased systolic blood pressure (SBP), decreased hemoglobin (Hb) and increased SII were independent risk factors for LVH in male patients, while older age, decreased Hb and increased uric acid (UA) were independent risk factors for LVH in female patients.
      Conclusion  LVH is common in non-dialysis patients with CKD, and there are more female patients. Anemia is a risk factor for LVH in all CKD patients while SII is a risk factor for LVH in men.
  • [1]
    JHA V, GARCIA-GARCIA G, ISEKI K, et al. Chronic kidney disease: global dimension and perspectives[J]. Lancet, 2013, 382(9888): 260-272. doi: 10.1016/S0140-6736(13)60687-X
    [2]
    PARK M, HSU C Y, LI Y M, et al. Associations between kidney function and subclinical cardiac abnormalities in CKD[J]. J Am Soc Nephrol, 2012, 23(10): 1725-1734. doi: 10.1681/ASN.2012020145
    [3]
    LONDON G M, PANNIER B, GUERIN A P, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study[J]. J Am Soc Nephrol, 2001, 12(12): 2759-2767. doi: 10.1681/ASN.V12122759
    [4]
    ZOCCALI C, BENEDETTO F A, MALLAMACI F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression[J]. Kidney Int, 2004, 65(4): 1492-1498. doi: 10.1111/j.1523-1755.2004.00530.x
    [5]
    MASIHA S, SUNDSTRÖM J, LIND L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women[J]. J Hum Hypertens, 27(1): 13-17. doi: 10.1038/jhh.2011.113
    [6]
    卢进, 张洪旭, 张育琴, 等. 维持性血液透析患者发生左心室肥厚的影响因素及RDW、hs-CRP的预测价值[J]. 中国医药导报, 2020, 17(12): 185-188. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202012047.htm
    [7]
    权钰迪, 周巧, 冯锦红, 等. 控制营养状态评分和血小板/淋巴细胞比值与腹膜透析患者左心室肥厚的关系[J]. 临床肾脏病杂志, 2020, 20(12): 946-950. doi: 10.3969/j.issn.1671-2390.2020.12.003
    [8]
    史倩雯, 胡雅玲, 范彦君, 等. 维持性血液透析患者中性粒细胞/淋巴细胞比值与左心室肥厚的临床研究[J]. 中国中西医结合肾病杂志, 2020, 21(1): 49-52. doi: 10.3969/j.issn.1009-587X.2020.01.016
    [9]
    韩博, 吴舜, 何先东, 等. 基于免疫细胞计数的系统性炎症反应指数在预测肾透明细胞癌患者预后中的作用研究[J]. 免疫学杂志, 2020, 36(2): 160-164, 184. https://www.cnki.com.cn/Article/CJFDTOTAL-MYXZ202002014.htm
    [10]
    罗永祥, 周涛. 全身免疫炎症指数对失代偿期肝硬化患者预后的评估价值[J]. 中国肝脏病杂志: 电子版, 2021, 13(1): 52-58. doi: 10.3969/j.issn.1674-7380.2021.01.009
    [11]
    STEVENS L A, LI S Y, WANG C C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP)[J]. Am J Kidney Dis, 2010, 55(3 Suppl 2): S23-S33.
    [12]
    PAOLETTI E, BELLINO D, CASSOTTANA P, et al. Left ventricular hypertrophy in nondiabetic predialysis CKD[J]. Am J Kidney Dis, 2005, 46(2): 320-327. doi: 10.1053/j.ajkd.2005.04.031
    [13]
    侯凡凡, 马志刚, 梅长林, 等. 中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J]. 中华医学杂志, 2005, 85(7): 458-463. doi: 10.3760/j:issn:0376-2491.2005.07.009
    [14]
    肖玉枝. 性激素在女性心血管疾病中的作用研究[J]. 中外健康文摘, 2010, 7(11): 104-106.
    [15]
    王朝霞, 吕吉元. 绝经后雌激素补充治疗与女性心血管疾病关系研究进展[J]. 中西医结合心脑血管病杂志, 2015, 13(4): 502-505. doi: 10.3969/j.issn.16721349.2015.04.029
    [16]
    孙宁玲, CHEN J W, 王继光, 等. 亚洲高血压合并左心室肥厚诊治专家共识[J]. 中华高血压杂志, 2016, 24(7): 619-627, 600. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGZ201607008.htm
    [17]
    冉兵, 晁玥, 安县朝, 等. 高血压左室肥厚伴左心衰竭的心脏彩超诊断分析[J]. 实用临床医药杂志, 2017, 21(23): 122-123. doi: 10.7619/jcmp.201723045
    [18]
    DI LULLO L, GORINI A, RUSSO D, et al. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment[J]. Cardiorenal Med, 2015, 5(4): 254-266. doi: 10.1159/000435838
    [19]
    YOUSIF N G, HADI N R, AL-AMRAN F, et al. Cardioprotective effects of irbesartan in polymicrobial Sepsis: the role of the p38MAPK/NF-κB signaling pathway[J]. Herz, 2018, 43(2): 140-145.
    [20]
    MATSUMOTO M, IO H, FURUKAWA M, et al. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography[J]. J Nephrol, 2012, 25(5): 794-801. doi: 10.5301/jn.5000066
    [21]
    LONDON G M. Left ventricular hypertrophy: why does it happen[J]. Nephrol Dial Transplant, 2003, 18(Suppl 8): viii2-viii6.
    [22]
    PORTOLÉS J, TORRALBO A, MARTIN P, et al. Cardiovascular effects of recombinant human erythropoietin in predialysis patients[J]. Am J Kidney Dis, 1997, 29(4): 541-548.
  • Related Articles

    [1]LIN Ningning, ZHAO Jiajia, FAN Junya, TIAN Xinyu, ZHANG Hui. Effects of three therapeutic schedules on cardiac functionand prognosis in patients undergoing percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 66-70. DOI: 10.7619/jcmp.20220829
    [2]YANG Junxia. Effect of rehabilitation nursing intervention on the improvement of quality of life in patients with cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 96-98, 102. DOI: 10.7619/jcmp.201912028
    [3]DING Xiaowei, CHEN Haiyan. Correlation study of continuous nursing on quality of life in patients with coronary artery disease after transradial coronary intervention[J]. Journal of Clinical Medicine in Practice, 2016, (22): 5-7,14. DOI: 10.7619/jcmp.201622002
    [4]GU Yongzhen. Effect of continuous nursing on the life quality and prognosis in children with asthma[J]. Journal of Clinical Medicine in Practice, 2015, (16): 113-115,119. DOI: 10.7619/jcmp.201516035
    [5]FAN Wenxia, XIAO Qiong, ZHOU Ke. Clinical observation on the effect of nursing intervention on psychologyand quality of life in patients with hemodialysis[J]. Journal of Clinical Medicine in Practice, 2015, (14): 36-38. DOI: 10.7619/jcmp.201514012
    [6]YANG Xiaoping, CHEN Qinjie, LI Lina, CHEN Qing. Quality of life in infertile couples and its influencing factors[J]. Journal of Clinical Medicine in Practice, 2015, (10): 71-74. DOI: 10.7619/jcmp.201510022
    [7]XIANG Mei, LIU Aihua. The impact of high quality nursing on adverse emotion and quality of life in patients with colorectal cancer after operation[J]. Journal of Clinical Medicine in Practice, 2015, (6): 62-64. DOI: 10.7619/jcmp.201506020
    [8]TU Xuemei. The effect and clinical analysis of continuous nursing intervention on prognosis of patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2015, (6): 4-6,22. DOI: 10.7619/jcmp.201506002
    [9]The effect of evidence-based nursing on postoperative complications and life quality of percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2014, (10): 3-5. DOI: 10.7619/jcmp.201410002
    [10]SONG Wenying. Influence of nursing intervention on the quality of life of patients with depression[J]. Journal of Clinical Medicine in Practice, 2013, (16): 147-149. DOI: 10.7619/jcmp.201316057
  • Cited by

    Periodical cited type(23)

    1. 邓玉珍. 健身气功八段锦锻炼结合睡眠干预对改善冠心病行冠状动脉介入术患者生活质量的效果观察. 心血管病防治知识. 2024(03): 68-72 .
    2. 王妍蝶,时贤君,秦庆祝. 认知行为干预结合健康教育对提高冠心病行经皮冠状动脉介入术后患者自我管理能力的效果. 慢性病学杂志. 2024(07): 1017-1020 .
    3. 刘翠琴,郭小燕. 基于运动疗法的康复护理对风湿性心脏病瓣膜置换患者术后的影响. 心血管病防治知识. 2024(10): 135-137 .
    4. 余媛媛,贺泽霞,张永佳,兰富霞,徐英. 4C干预模式对老年经皮冠状动脉介入术后患者的影响. 实用临床医药杂志. 2023(16): 68-71 . 本站查看
    5. 梁夷凤. 冠心病患者PCI术后应用基于5E理念的综合康复护理的效果分析. 中外医疗. 2023(23): 155-159 .
    6. 吴伟,高鹃. 双心护理模式对冠心病经皮冠状动脉介入治疗患者心理健康状况和护理满意度的影响观察. 基层医学论坛. 2022(03): 87-89 .
    7. 吴张平. 早期心脏康复训练对PCI术后患者的影响. 继续医学教育. 2022(05): 125-128 .
    8. 牛杜娟,尚雯,张红. 以FTS理论为指导的系统化护理模式对PCI术后患者心功能的影响. 保健医学研究与实践. 2022(07): 82-85 .
    9. 王琳,张亚铮,袁媛. 基于CSMS量表和CQQC的5E康复护理在冠心病PCI术后患者康复中的应用效果. 河北医药. 2022(14): 2228-2231 .
    10. 刘娟,刘芳,张静. 临床护理路径在冠状动脉搭桥术患者术后康复中的应用效果研究. 中西医结合心血管病电子杂志. 2022(11): 4-6+13 .
    11. 贾艳静,王新宙. 优质护理应用于老年冠心病患者护理中对患者生活质量和疗效的影响. 中国药物与临床. 2021(08): 1409-1411 .
    12. 邹蓉蓉,李天兰,吴莉玫,尹艳华. 优化康复护理流程对PCl术后患者心肺功能以及预后的影响分析. 心血管病防治知识. 2021(04): 59-61+64 .
    13. 宋敏. 整体化康复护理措施在冠心病患者中的应用. 黑龙江中医药. 2021(01): 294-295 .
    14. 张善婷,冯俊,刘洋. 冠心病患者PCI介入治疗中的护患沟通对治疗依从性的影响. 河北医药. 2021(11): 1743-1746 .
    15. 胥加艳,郭晓鑫. 5E护理在冠心病病人PCI术后康复中的应用研究. 循证护理. 2021(08): 1108-1111 .
    16. 郭秀蝶,郑雅娟,林晨芳,吴群,张亚真. 评判性思维护理对缺铁性贫血伴缺血性心脏病患者贫血及心功能的影响. 心血管病防治知识. 2021(32): 26-29 .
    17. 柯晓玲,吴娟娟. 早期康复护理对老年心血管病患者的效果观察. 心血管病防治知识(学术版). 2020(14): 68-70 .
    18. 孙婧,李萍. 冠心病患者的系统性心肺康复护理. 实用临床医药杂志. 2020(14): 122-125 . 本站查看
    19. 陈燕华,张苗. 慢性肾脏病合并冠心病患者冠状动脉介入术后行血液透析护理研究. 山西医药杂志. 2020(18): 2548-2549 .
    20. 刘姝娉. 过渡期康复护理措施对老年心血管疾病患者功能恢复及预后的影响. 心血管病防治知识. 2020(24): 70-72 .
    21. 郑燕,常莉,刘桂玲,刘晚霞. 常规护理联合心脏康复护理对冠心病介入治疗后心功能的改善作用. 贵州医药. 2020(10): 1662-1663 .
    22. 张书明. 探讨冠心病冠状动脉介入术患者心脏康复护理模式的建立对促进患者术后恢复的意义. 心血管病防治知识. 2020(31): 58-60 .
    23. 聂志鑫. 时机理论下的家庭护理对经皮冠状动脉性心脏病介入治疗后患者预后和生活质量的影响. 中西医结合护理(中英文). 2020(11): 59-62 .

    Other cited types(0)

Catalog

    Article views (267) PDF downloads (14) Cited by(23)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return